Can Ketogenic Dietary Interventions Slow Disease Progression In ADPKD

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney condition, affecting about 1 in 2,500 people and leading to kidney failure over time. The disease causes fluid-filled cysts to grow in the kidneys, gradually reducing their function. Currently, there's only one approved medication called tolvaptan that can slow disease progression by 30-50%, but it comes with significant side effects including frequent urination and potential liver problems.

Many patients with ADPKD ask their doctors whether changing their diet or lifestyle could help slow their disease progression. Recent laboratory studies in animal models of polycystic kidney disease have shown promising results with certain dietary approaches, particularly ketogenic diets (very low-carb, high-fat diets), caloric restriction, and increased water intake. These interventions appeared to help preserve kidney function in experimental settings.

This editorial discusses a new patient survey study that looked at ADPKD patients who chose to try ketogenic diets on their own. While the full results aren't detailed in this excerpt, the authors note that the survey provides valuable insights into how well patients tolerate ketogenic diets and what potential benefits or risks they might experience. This real-world data could help inform future clinical trials testing whether ketogenic diets truly help humans with ADPKD.

For patients interested in metabolic health and longevity, this research highlights how dietary interventions might influence disease progression beyond just general health benefits. However, it's important to note that these are early findings, and patients with ADPKD should work closely with their healthcare providers before making significant dietary changes, as more rigorous clinical trials are needed to confirm whether ketogenic diets are safe and effective for this condition.